文献速递创面修复瘢痕与激光

超越手术刀:化脓性汗腺炎手术切除后并发症的患者风险因素评估

Looking beyond the scalpel: Assessing patient risk factors for complications following surgical excision of hidradenitis suppurativa.
PubMed 文献 · Burns · 2025-12-09

该回顾性研究分析了239例接受化脓性汗腺炎(HS)广泛局部切除术的患者,发现Hurley III期患者并发症率更高,白人种族与并发症风险降低相关,而既往免疫调节剂使用与风险增加相关,提示疾病严重程度和社会人口学差异影响术后结局。

要点

  • Hurley III期HS患者术后并发症率显著高于I/II期。
  • 白人种族与并发症风险降低独立相关,既往免疫调节剂使用与风险增加相关。
  • 需关注HS手术患者的社会人口学差异及疾病复杂度对预后的影响。

核心结论

  • 疾病严重程度和社会人口学因素显著影响HS手术结局,Hurley III期患者并发症率更高。
  • 白人种族与并发症风险降低相关,既往免疫调节剂使用与风险增加相关。

研究设计与样本

  • IRB批准的回顾性综述,纳入2015年12月1日至2022年6月2日期间接受原发性或继发性广泛局部切除术的≥18岁HS患者,最终239例符合标准。

主要发现

  • 共报告284例并发症,更严重的并发症(如皮瓣/移植失败、肥厚性肉芽、瘢痕疙瘩形成、肥厚性瘢痕)主要发生在III期。
  • 「其他」并发症率在Hurley I、II、III期分别为7%、2%、21%(p < 0.01),III期最高。
  • 非计划再手术率在I、II、III期分别为27%、4%、18%(p = 0.01)。
  • 回归分析显示白人种族与较低并发症风险显著相关(p = 0.039),既往免疫调节剂使用增加风险(p = 0.02)。

临床怎么用

  • 对Hurley III期HS患者应加强术前评估和术后监测,警惕严重并发症。
  • 关注患者种族和免疫调节剂使用史,个体化制定围手术期管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hidradenitis suppurativa (HS) is a chronic inflammatory disease affecting intertriginous skin. Severe HS presents a reconstructive challenge due to high complication rates; however, risk factors for complications are understudied. This study examines patient-level risk factors for increased complications and operative techniques used at our institution. METHODS: We conducted an IRB-approved retrospective review of patients (≥18 years) who underwent primary or secondary wide local excision of HS between 12/1/2015-06/02/2022. Sociodemographic, intraoperative, and complication data were analyzed using descriptive statistics and Fisher's exact tests. Multiple logistic regression was used to determine the association between patient demographic factors and occurrence of any complications. Significance was set at p < 0.05. RESULTS: Of the 347 patients identified, 239 met inclusion criteria (median age 35 years, follow-up time 13 months). Most patients were Black (76 %) and non-Hispanic/non-Latino (95 %). Common HS risk factors included current smoking (20 %), former smoking (18 %), and diabetes (15 %). Patients were classified as Hurley Stage I (6 %), II (23 %), and III (45 %). Overall, 284 complications were reported, with more severe complications (e.g., flap/graft failure, hypertrophic granulation, keloid formation, hypertrophic scarring) predominantly occurring in Stage III. Complication rates of "other" complications differed significantly across Hurley stages I, II, and III (7 %, 2 %, 21 %, respectively; p < 0.01), with Stage III having the highest rates. Unplanned reoperations also demonstrated significant differences across stages (27 %, 4 %, 18 %, respectively; p = 0.01). Regression analysis showed White race was significantly associated with lower complication risk (p = 0.039), while prior immunomodulator use increased risk (p = 0.02). CONCLUSIONS: Disease severity and demographic factors significantly impact HS surgical outcomes. Patients in Hurley Stage III experienced higher complication rates. White race was associated with decreased complication risk while prior immunomodulator use was associated with increased complication risk, suggesting sociodemographic disparities and disease complexity contribute to poorer post-operative outcomes.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Zhu L, Khan IF, Tiongco RFP, et al. Looking beyond the scalpel: Assessing patient risk factors for complications following surgical excision of hidradenitis suppurativa. Burns. 2025. PMID: 41447905. doi:10.1016/j.burns.2025.107822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。